Prot# 32101-2-03: A Randomized, Double Blind, Placebo Controlled, Parallel Group Study of the Safety & Efficacy of 1% & 2% Nanocrystalline Silver Cream(NPI 32101) Applied 2x Daily in Pediatric & Adolescent Subjects w/Mild to Moderate Atopic Dermatitis(AD)

Project: Research project

Project Details

StatusFinished
Effective start/end date10/28/05 → 7/31/07

Funding

  • NUCRYST Pharmaceuticals Inc. (32101-2-03)